实用老年医学 ›› 2023, Vol. 37 ›› Issue (10): 973-977.doi: 10.3969/j.issn.1003-9198.2023.10.001
• 专题论坛 • 下一篇
张授尧, 张星贺, 夏世金
收稿日期:
2023-08-10
出版日期:
2023-10-20
发布日期:
2023-10-19
通讯作者:
夏世金,Email:xiashijinhd@163.com
作者简介:
夏世金 教授
基金资助:
Received:
2023-08-10
Online:
2023-10-20
Published:
2023-10-19
中图分类号:
张授尧, 张星贺, 夏世金. 血管衰老与老年血管疾病[J]. 实用老年医学, 2023, 37(10): 973-977.
[1] PENLIOGLOU T, STOIAN A P, PAPANAS N. Diabetes, vascular aging and stroke: old dogs, new tricks?[J]. J Clin Med, 2021, 10(19):4620. [2] QIU Y, LIU Y, LIU X, et al. Novel update of interventional strategies of vascular aging in humans[J]. Aging Med: Milton, 2020, 3(3): 146-150. [3] 张存泰,陶军,田小利,等.血管衰老临床评估与干预中国专家共识(2018)[J]. 中华老年病研究电子杂志, 2019, 6(1): 1-8. [4] HEFFERNAN K S, FAHS C A, RANADIVE S M, et al. L-arginine as a nutritional prophylaxis against vascular endothelial dysfunction with aging[J]. J Cardiovasc Pharmacol Ther, 2010, 15(1): 17-23. [5] HAYASHI T, YANO K, MATSUI-HIRAI H, et al. Nitric oxide and endothelial cellular senescence[J]. Pharmacol Ther, 2008, 120(3): 333-339. [6] KONDO T, HIROSE M, KAGEYAMA K. Roles of oxidative stress and redox regulation in atherosclerosis[J]. J Atheroscler Thromb, 2009, 16(5): 532-538. [7] MINAMINO T, KOMURO I. Vascular cell senescence: contribution to atherosclerosis[J]. Circ Res, 2007, 100(1): 15-26. [8] NICOLL R, HENEIN M Y. The predictive value of arterial and valvular calcification for mortality and cardiovascular events[J]. Int J Cardiol Heart Vessel, 2014, 3: 1-5. [9] HO C Y, SHANAHAN C M. Medial arterial calcification: an overlooked player in peripheral arterial disease[J]. Arterioscler Thromb Vasc Biol, 2016, 36(8): 1475-1482. [10] ADENEY K L, SISCOVICK D S, IX J H, et al. Association of serum phosphate with vascular and valvular calcification in moderate CKD[J]. J Am Soc Nephrol, 2009, 20(2): 381-387. [11] CENERI N, ZHAO L, YOUNG B D, et al. Rac2 modulates atherosclerotic calcification by regulating macrophage interleukin-1beta production[J]. Arterioscler Thromb Vasc Biol, 2017, 37(2): 328-340. [12] VAN CAMPENHOUT A, GOLLEDGE J. Osteoprotegerin, vascular calcification and atherosclerosis[J]. Atherosclerosis, 2009, 204(2): 321-329. [13] DE MARE A, OPDEBEECK B, NEVEN E, et al. Sclerostin protects against vascular calcification development in mice[J]. J Bone Miner Res, 2022, 37(4): 687-699. [14] RATTAZZI M, BERTACCO E, DEL V A, et al. Aortic valve calcification in chronic kidney disease[J]. Nephrol Dial Transplant, 2013, 28(12): 2968-2976. [15] LOWERISON M R, SEKARAN N, ZHANG W, et al. Aging-related cerebral microvascular changes visualized using ultrasound localization microscopy in the living mouse[J]. Sci Rep, 2022, 12(1): 619. [16] DESJARDINS M, BERTI R, LEFEBVRE J, et al. Aging-related differences in cerebral capillary blood flow in anesthetized rats[J]. Neurobiol Aging, 2014, 35(8): 1947-1955. [17] BROWN W R, MOODY D M, THORE C R, et al. Vascular dementia in leukoaraiosis may be a consequence of capillary loss not only in the lesions, but in normal-appearing white matter and cortex as well[J]. J Neurol Sci, 2007, 257(1/2): 62-66. [18] BULLITT E, ZENG D, MORTAMET B, et al. The effects of healthy aging on intracerebral blood vessels visualized by magnetic resonance angiography[J]. Neurobiol Aging, 2010, 31(2): 290-300. [19] SIES H, BERNDT C, JONES D P. Oxidative stress[J]. Annu Rev Biochem, 2017, 86: 715-748. [20] LI X, LI C, ZHANG W, et al. Inflammation and aging: signaling pathways and intervention therapies[J]. Signal Transduct Target Ther, 2023, 8(1): 239. [21] GIUNTA S, WEI Y, XU K, et al. Cold-inflammaging: when a state of homeostatic-imbalance associated with aging precedes the low-grade pro-inflammatory-state (inflammaging): meaning, evolution, inflammaging phenotypes[J]. Clin Exp Pharmacol Physiol, 2022, 49(9): 925-934. [22] LIBERALE L, BADIMON L, MONTECUCCO F, et al. Inflammation, aging, and cardiovascular disease: JACC review topic of the week[J]. J Am Coll Cardiol, 2022, 79(8): 837-847. [23] FRANCESCHI C, BONAFE M, VALENSIN S, et al. Inflamm-aging. An evolutionary perspective on immunosenescence[J]. Ann N Y Acad Sci, 2000, 908: 244-254. [24] 夏世金,刘小雨,黄建华,等. 炎性衰老的研究进展[J]. 中华老年医学杂志, 2007, 26(7): 550-553. [25] CSISZAR A, UNGVARI Z, EDWARDS J G, et al. Aging-induced phenotypic changes and oxidative stress impair coronary arteriolar function[J]. Circ Res, 2002, 90(11): 1159-1166. [26] WANG M, JIANG L, MONTICONE R E, et al. Proinflammation: the key to arterial aging[J]. Trends Endocrinol Metab, 2014, 25(2): 72-79. [27] DE LA FUENTE M, MIQUEL J. An update of the oxidation-inflammation theory of aging: the involvement of the immune system in oxi-inflamm-aging[J]. Curr Pharm Des, 2009, 15(26): 3003-3026. [28] MARTINEZ D T I, CEPRIAN N, DIAZ-DEL C E, et al. The role of immune cells in oxi-inflamm-aging[J]. Cells, 2021, 10(11). [29] WEI Y, GIUNTA S, XIA S. Hypoxia in aging and aging-related diseases: mechanism and therapeutic strategies[J]. Int J Mol Sci, 2022, 23(15):8165. [30] ERUSALIMSKY J D. Oxidative stress, telomeres and cellular senescence: what non-drug interventions might break the link?[J]. Free Radic Biol Med, 2020, 150: 87-95. [31] KWON S M, HONG S M, LEE Y K, et al. Metabolic features and regulation in cell senescence[J]. BMB Rep, 2019, 52(1): 5-12. [32] CHAPMAN J, FIELDER E, PASSOS J F. Mitochondrial dysfunction and cell senescence: deciphering a complex relationship[J]. FEBS Lett, 2019, 593(13): 1566-1579. [33] FOOTE K, REINHOLD J, YU E, et al. Restoring mitochondrial DNA copy number preserves mitochondrial function and delays vascular aging in mice[J]. Aging Cell, 2018, 17(4): e12773. [34] ABDELLATIF M, RAINER P P, SEDEJ S, et al. Hallmarks of cardiovascular ageing[J]. Nat Rev Cardiol, 2023. [35] SADOUL K, WANG J, DIAGOURAGA B, et al. The tale of protein lysine acetylation in the cytoplasm[J]. J Biomed Biotechnol, 2011, 2011: 970382. [36] HAN X, LING S, GAN W, et al. 2,3,5,4'-tetrahydroxystilbene-2-O-beta-d-glucoside ameliorates vascular senescence and improves blood flow involving a mechanism of p53 deacetylation[J]. Atherosclerosis, 2012, 225(1): 76-82. [37] ZARZUELO M J, LOPEZ-SEPULVEDA R, SANCHEZ M, et al. SIRT1 inhibits NADPH oxidase activation and protects endothelial function in the rat aorta: implications for vascular aging[J]. Biochem Pharmacol, 2013, 85(9): 1288-1296. [38] GAO X, YU X, ZHANG C, et al. Telomeres and mitochondrial metabolism: implications for cellular senescence and age-related diseases[J]. Stem Cell Rev Rep, 2022, 18(7): 2315-2327. [39] MORGAN R G, WALKER A E, TROTT D W, et al. Induced Trf2 deletion leads to aging vascular phenotype in mice associated with arterial telomere uncapping, senescence signaling, and oxidative stress[J]. J Mol Cell Cardiol, 2019, 127: 74-82. [40] BLOOM S I, LIU Y, TUCKER J R, et al. Endothelial cell telomere dysfunction induces senescence and results in vascular and metabolic impairments[J]. Aging Cell, 2023: e13875. [41] KHODADI E. Platelet function in cardiovascular disease: activation of molecules and activation by molecules[J]. Cardiovasc Toxicol, 2020, 20(1): 1-10. [42] 张翥,陶亮亮,刘品刚,等.老年冠心病患者血小板聚集率与心血管不良事件的关系[J]. 中国老年学杂志, 2021, 41(14): 2924-2927. [43] 张琳,李燕英,孟琦,等.老年2型糖尿病与血小板、凝血及纤溶功能的相关性[J]. 昆明医科大学学报, 2021, 42(11): 62-67. [44] HALDAR R N. Global brief on hypertension: silent killer, global public health crisis[J]. Indian J Physical Med Rehabil, 2013, 24(1): 2. [45] BOUTOUYRIE P, CHOWIENCZYK P, HUMPHREY J D, et al. Arterial stiffness and cardiovascular risk in hypertension[J]. Circ Res, 2021, 128(7): 864-886. [46] CUNHA P G, BOUTOUYRIE P, NILSSON P M, et al. Early vascular ageing (EVA): definitions and clinical applicability[J]. Curr Hypertens Rev, 2017, 13(1): 8-15. [47] 胡肖依,袁平,刘锦铭. 炎性衰老与支气管哮喘[J]. 老年医学与保健, 2022, 28(6): 1173-1177. [48] 游乾义,胡明冬. 炎性衰老对老年重症肺炎预后的影响[J]. 老年医学与保健, 2022, 28(6): 1177-1180. [49] 丁薇,雷撼. 炎性衰老与肺动脉高压[J]. 老年医学与保健, 2022, 28(6): 1169-1172. [50] LIU L, WEI Y, GIUNTA S, et al. Potential role of cellular senescence in pulmonary arterial hypertension[J]. Clin Exp Pharmacol Physiol, 2022, 49(10): 1042-1049. [51] TSIOUFIS C, DIMITRIADIS K, SELIMA M, et al. Low-grade inflammation and hypoadiponectinaemia have an additive detrimental effect on aortic stiffness in essential hypertensive patients[J]. Eur Heart J, 2007, 28(9): 1162-1169. [52] MA L, LI Y. SIRT1: role in cardiovascular biology[J]. Clin Chim Acta, 2015, 440: 8-15. [53] LUO X Y, QU S L, TANG Z H, et al. SIRT1 in cardiovascular aging[J]. Clin Chim Acta, 2014, 437: 106-114. [54] SWEENEY M D, MONTAGNE A, SAGARE A P, et al. Vascular dysfunction-the disregarded partner of Alzheimer's disease[J]. Alzheimers Dement, 2019, 15(1): 158-167. [55] HERRINGTON W, LACEY B, SHERLIKER P, et al. Epidemiology of atherosclerosis and the potential to reduce the global burden of atherothrombotic disease[J]. Circ Res, 2016, 118(4): 535-546. [56] WANG J C, BENNETT M. Aging and atherosclerosis: mechanisms, functional consequences, and potential therapeutics for cellular senescence[J]. Circ Res, 2012, 111(2): 245-259. [57] GUPTA A, IADECOLA C. Impaired Aβ clearance: a potential link between atherosclerosis and Alzheimer's disease[J]. Front Aging Neurosci, 2015, 7: 115. [58] WANG M, ZHANG J, JIANG L Q, et al. Proinflammatory profile within the grossly normal aged human aortic wall[J]. Hypertension, 2007, 50(1): 219-227. [59] HASHIMOTO M, ISHINAGA Y, HONDA M, et al. Age-related increase in the uptake of acetylated low density lipoprotein into cultured endothelial cells from rat aorta[J]. Exp Gerontol, 1991, 26(4): 397-406. [60] WANG Y, FENG X, SHEN B, et al. Is Vascular amyloidosis intertwined with arterial aging, hypertension and atherosclerosis?[J]. Front Genet, 2017, 8: 126. |
[1] | 陈映泉, 钟勇. 心血管老化的机制、标志物和治疗[J]. 实用老年医学, 2024, 38(3): 299-303. |
[2] | 范婷泳, 袁丽, 杨小玲, 陈茜. Caprini量表评估老年糖尿病病人静脉血栓栓塞症的效果[J]. 实用老年医学, 2023, 37(12): 1233-1237. |
[3] | 白晓瑜, 张君, 赵鹏, 魏梅, 邱亚辉, 冯雪娟. 5次坐立试验与老年PCI病人心功能及生活质量的相关性研究[J]. 实用老年医学, 2023, 37(8): 777-780. |
[4] | 高伟飞, 李鹏, 乔镇, 马利娜. Padua评分对老年住院病人发生静脉血栓栓塞症的预测价值[J]. 实用老年医学, 2023, 37(8): 803-805. |
[5] | 王朝阳, 赵丽娜, 梁浩, 陈淑霞, 谷剑. 纤维蛋白原与白蛋白比值对老年疑似冠心病病人冠脉病变程度的预测价值[J]. 实用老年医学, 2023, 37(8): 806-810. |
[6] | 杨少琦, 杨洋, 邓丽娜, 翟志欣. 系统免疫炎症指数对老年射血分数减低型心力衰竭病人下肢深静脉血栓形成的预测价值[J]. 实用老年医学, 2023, 37(7): 695-699. |
[7] | 陈顺中. 慢性脑供血不足的中医治疗研究进展[J]. 实用老年医学, 2023, 37(2): 124-127. |
[8] | 殷亚昕, 刘润梅, 翟红霞, 李良, 张津津, 陈海威, 王磊, 李娜, 夏云峰. 辛伐他汀对动脉粥样硬化大鼠高迁移率族蛋白1表达的影响[J]. 实用老年医学, 2010, 24(2): 128-131. |
[9] | 孔超敏, 吕彩霞, 姚丽霞, 苑晓烨, 王素星, 邵伟华, 白雪冬, 吴思思, 杨爽, 李芳. 老年内科住院病人血清脂蛋白(a)与静脉血栓栓塞症风险的相关性研究[J]. 实用老年医学, 2024, 38(7): 705-708. |
阅读次数 | ||||||
全文 |
|
|||||
摘要 |
|
|||||
|